Literature DB >> 12590733

Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments.

Muriel Gaubin1, Cristina Fanutti, Zohar Mishal, Antoine Durrbach, Piergiuseppe De Berardinis, Rossella Sartorius, Giovanna Del Pozzo, John Guardiola, Richard N Perham, Dominique Piatier-Tonneau.   

Abstract

Virions of filamentous bacteriophage fd are capable of displaying multiple copies of peptide epitopes and generating powerful immune responses to them. To investigate the antigen processing mechanisms in human B cell lines used as antigen presenting cells, the major coat protein (pVIII) in intact virions was fluorescently labeled, and its localization in various intracellular compartments was followed using confocal microscopy. We show that the virions were taken up and processed to yield peptides that reach both the major histocompatibility complex (MHC) class II compartment and the endoplasmic reticulum. Moreover, when exposed to bacteriophages displaying a cytotoxic T lymphocyte (CTL) epitope from the reverse transcriptase of human immunodeficiency virus type-1 (HIV-1), B cells were lysed by specific cytotoxic lymphocytes. This confirms that filamentous bacteriophage virions are capable of being taken up and processed efficiently by MHC class I and class II pathways, even in nonprofessional antigen presenting cells. These remarkable features explain, at least in part, the unexpected ability of virions displaying foreign T-cell epitopes to prime strong T-helper-dependent CTL responses. These findings have important implications for the development of peptide-based vaccines, using filamentous bacteriophage virions as scaffolds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590733     DOI: 10.1089/104454903321112451

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  28 in total

1.  Detection of HLA class II-dependent T helper antigen using antigen phage display.

Authors:  R Somasundaram; K Satyamoorthy; L Caputo; H Yssel; D Herlyn
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

2.  Delivery strategies for novel vaccine formulations.

Authors:  Maria Trovato; Shelly J Krebs; Nancy L Haigwood; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2012-02-12

3.  Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.

Authors:  Johanna M Sweere; Jonas D Van Belleghem; Heather Ishak; Michelle S Bach; Medeea Popescu; Vivekananda Sunkari; Gernot Kaber; Robert Manasherob; Gina A Suh; Xiou Cao; Christiaan R de Vries; Dung N Lam; Payton L Marshall; Maria Birukova; Ethan Katznelson; Daniel V Lazzareschi; Swathi Balaji; Sundeep G Keswani; Thomas R Hawn; Patrick R Secor; Paul L Bollyky
Journal:  Science       Date:  2019-03-29       Impact factor: 47.728

Review 4.  Therapeutic and prophylactic applications of bacteriophage components in modern medicine.

Authors:  Sankar Adhya; Carl R Merril; Biswajit Biswas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 5.  Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.

Authors:  Pan Tao; Jingen Zhu; Marthandan Mahalingam; Himanshu Batra; Venigalla B Rao
Journal:  Adv Drug Deliv Rev       Date:  2018-07-06       Impact factor: 15.470

6.  Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection.

Authors:  Yanyan Huai; Shuai Dong; Ye Zhu; Xin Li; Binrui Cao; Xiang Gao; Mingying Yang; Li Wang; Chuanbin Mao
Journal:  Adv Healthc Mater       Date:  2016-02-18       Impact factor: 9.933

7.  Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses.

Authors:  Giovanna Del Pozzo; Dina Mascolo; Rossella Sartorius; Alessandra Citro; Pasquale Barba; Luciana D'Apice; Piergiuseppe De Berardinis
Journal:  J Biomed Biotechnol       Date:  2010-04-29

8.  Biodistribution of filamentous phage peptide libraries in mice.

Authors:  Jun Zou; Marie T Dickerson; Nellie K Owen; Linda A Landon; Susan L Deutscher
Journal:  Mol Biol Rep       Date:  2004-06       Impact factor: 2.316

Review 9.  Filamentous bacteriophage fd as an antigen delivery system in vaccination.

Authors:  Antonella Prisco; Piergiuseppe De Berardinis
Journal:  Int J Mol Sci       Date:  2012-04-24       Impact factor: 6.208

Review 10.  Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.

Authors:  Kevin A Henry; Mehdi Arbabi-Ghahroudi; Jamie K Scott
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.